The type b capsular polysaccharide as a virulence determinant of Haemophilus influenzae: studies using clinical isolates and laboratory transformants

J Infect Dis. 1981 Apr;143(4):517-24. doi: 10.1093/infdis/143.4.517.

Abstract

Haemophilus influenzae organisms elaborating one of six capsular polysaccharides (types a-f) colonize the respiratory tract of humans, but only type b strains commonly cause systemic infections. To investigate the role of capsular polysaccharides as virulence determinants, rats were inoculated with capsulated (types a-f) or noncapsulated clinical isolates or with laboratory-derived type b and type d transformants of a noncapsulated strain. After intraperitoneal inoculation, all capsulated strains possessed the potential for systemic infection, but type b strains were more virulent; noncapsulated strains were noninvasive. After intranasal inoculation, only type b strains were invasive. There was no difference in efficiency of nasopharyngeal colonization between type b and type d transformants. After intravenous inoculation, only type b strains resulted in persistent bacteremia. Thus, type b strains--clinical isolates or transformants--display unique virulence characteristics. These data suggest that elaboration of type b capsule is necessary and sufficient for this virulence of H. influenzae type b in the rat.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Administration, Intranasal
  • Animals
  • Blood Circulation
  • Haemophilus Infections / etiology*
  • Haemophilus influenzae / genetics*
  • Haemophilus influenzae / pathogenicity
  • Injections, Intraperitoneal
  • Injections, Intravenous
  • Polysaccharides, Bacterial*
  • Rats
  • Transformation, Bacterial*
  • Virulence

Substances

  • Polysaccharides, Bacterial